These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6114324)

  • 1. Bone formation and resorption as the determinants of trabecular bone volume in postmenopausal osteoporosis.
    Nordin BE; Aaron J; Speed R; Crilly RG
    Lancet; 1981 Aug; 2(8241):277-9. PubMed ID: 6114324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone formation and resorption as the determinants of trabecular bone volume in normal and osteoporotic men.
    Nordin BE; Aaron J; Speed R; Francis RM; Makins N
    Scott Med J; 1984 Jul; 29(3):171-5. PubMed ID: 6533788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone formation and resorption in postmenopausal osteoporosis.
    Nordin BE
    Lancet; 1981 Sep; 2(8248):695. PubMed ID: 6116072
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone formation and resorption in postmenopausal osteoporosis.
    Darby AJ
    Lancet; 1981 Sep; 2(8245):536. PubMed ID: 6115291
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term prediction of three-dimensional bone architecture in simulations of pre-, peri- and post-menopausal microstructural bone remodeling.
    Müller R
    Osteoporos Int; 2005 Mar; 16 Suppl 2():S25-35. PubMed ID: 15340800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.
    Stevenson JC; Abeyasekera G; Hillyard CJ; Phang KG; MacIntyre I; Campbell S; Townsend PT; Young O; Whitehead MI
    Lancet; 1981 Mar; 1(8222):693-5. PubMed ID: 6110915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.
    Riggs BL; Khosla S; Melton LJ
    J Bone Miner Res; 1998 May; 13(5):763-73. PubMed ID: 9610739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E
    Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The assessment of bone formation and bone resorption in osteoporosis: a comparison between tetracycline-based iliac histomorphometry and whole body 85Sr kinetics.
    Reeve J; Arlot ME; Chavassieux PM; Edouard C; Green JR; Hesp R; Tellez M; Meunier PJ
    J Bone Miner Res; 1987 Dec; 2(6):479-89. PubMed ID: 3455632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone histomorphometry in the pathophysiological evaluation of primary and secondary osteoporosis and various treatment modalities.
    Steiniche T
    APMIS Suppl; 1995; 51():1-44. PubMed ID: 7669370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vertebral bone loss in menopause.
    Isaia GC; Salamano G; Mussetta M; Molinatti GM
    Exp Gerontol; 1990; 25(3-4):303-7. PubMed ID: 2226665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms underlying the effects of phosphate and calcitonin on bone histology in postmenopausal osteoporosis.
    Marie PJ; Caulin F
    Bone; 1986; 7(1):17-22. PubMed ID: 3964494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding coupling between bone resorption and formation: are reversal cells the missing link?
    Andersen TL; Abdelgawad ME; Kristensen HB; Hauge EM; Rolighed L; Bollerslev J; Kjærsgaard-Andersen P; Delaisse JM
    Am J Pathol; 2013 Jul; 183(1):235-46. PubMed ID: 23747107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active bone turnover of the cortico-endosteal envelope in postmenopausal osteoporosis.
    Brown JP; Delmas PD; Arlot M; Meunier PJ
    J Clin Endocrinol Metab; 1987 May; 64(5):954-9. PubMed ID: 3494038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance and pathogenesis of osteoporosis.
    Nordin BE
    Br Med J; 1971 Mar; 1(5749):571-6. PubMed ID: 5548297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis.
    Eastell R; Calvo MS; Burritt MF; Offord KP; Russell RG; Riggs BL
    J Clin Endocrinol Metab; 1992 Mar; 74(3):487-94. PubMed ID: 1740481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise and osteoporosis.
    Sinaki M
    Arch Phys Med Rehabil; 1989 Mar; 70(3):220-9. PubMed ID: 2647057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal osteoporosis.
    Silverberg SJ; Lindsay R
    Med Clin North Am; 1987 Jan; 71(1):41-57. PubMed ID: 3543542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone histology in postmenopausal osteoporosis--variations in cellular activity].
    Lozo P; Krpan D; Krvavica A; Vukelić Baturić T; Fistonić I; Kusec V
    Acta Med Croatica; 2004; 58(1):5-11. PubMed ID: 15125387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alfacalcidol prevents age-related bone loss and causes an atypical pattern of bone formation in aged male rats.
    Li M; Healy DR; Li Y; Simmons HA; Su M; Jee WS; Shen VW; Thompson DD
    J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):22-32. PubMed ID: 15615075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.